Robin Bannister's guest appearances

Robin Bannister

Finding Genius Podcast

FutureTech Podcast

Laura Potterat

Marc Guell

Paul Turner

Jan Vijg

Eleftherios Mylonakis

Cory Kidd

Charles C.J

Helius Medical Technologies

Patrick McKeown

Michael G. Surette

Katelyn Parsons

John Tucker

Jake Kushner

Erik Gunther

Kim Kush

OwlTail

“My reason for wanting to start the company was a very simple one actually, and a very personal one: my wife had cancer, she had breast cancer…misdiagnosed and then finally correctly diagnosed in 2005. She became metastatic in 2010,” says Robin Bannister, Founder and Director of Research and Development at Care Oncology Clinic. Dr. Bannister had spent his entire professional life studying different pharmaceuticals and trying to understand the ways in which old drugs could be repurposed, but now there was a new level of urgency to his work. He knew he had to act quickly. To find the drug he was looking for, he first had to reduce the list of 5,000 or so drugs to a list that was more manageable, and he did this by focusing on those that had a long history of safe use and mild side effects, particularly in cancer patients. The basis of the treatment provided at Care Oncology Clinic takes advantage of the Warburg effect—the metabolic processes used by cancer cells to stay alive and grow. The Care Oncology protocol employs drugs which, simply put, make it exceedingly difficult for cancer cells to survive by limiting the resources they use in order to defend themselves in harsh environments—environments created not only by the standard of care for cancer, but also the body’s own immune system. By tuning in to today’s episode, you will learn the details of this and more, including:  What an efflux pump is and how exactly it’s used by cancer cells Why the standard of care is not perfect, but often has a part to play in the treatment of cancer How the Care Oncology protocol can serve as an adjunct to the treatment for all cancer types  Locate the Care Oncology USA website at https://careoncology.com/.

“My reason for wanting to start the company was a very simple one actually, and a very personal one: my wife had cancer, she had breast cancer…misdiagnosed and then finally correctly diagnosed in 2005. She became metastatic in 2010,” says Robin Bannister, Founder and Director of Research and Development at Care Oncology Clinic. Dr. Bannister had spent his entire professional life studying different pharmaceuticals and trying to understand the ways in which old drugs could be repurposed, but now there was a new level of urgency to his work. He knew he had to act quickly. To find the drug he was looking for, he first had to reduce the list of 5,000 or so drugs to a list that was more manageable, and he did this by focusing on those that had a long history of safe use and mild side effects, particularly in cancer patients. The basis of the treatment provided at Care Oncology Clinic takes advantage of the Warburg effect—the metabolic processes used by cancer cells to stay alive and grow. The Care Oncology protocol employs drugs which, simply put, make it exceedingly difficult for cancer cells to survive by limiting the resources they use in order to defend themselves in harsh environments—environments created not only by the standard of care for cancer, but also the body’s own immune system. By tuning in to today’s episode, you will learn the details of this and more, including: <ul> <li>What an efflux pump is and how exactly it’s used by cancer cells</li> <li>Why the standard of care is not perfect, but often has a part to play in the treatment of cancer</li> <li>How the Care Oncology protocol can serve as an adjunct to the treatment for all cancer types</li> </ul> Locate the <a href="https://www.futuretechpodcast.com/podcasts/combatting-cancer-charles-j-meakin-md-mha-medical-director-care-oncology-clinic-usa-finding-new-ways-to-fight-cancer-combinations-of-drugs-and-rethinking-treatment/" rel="nofollow" target="_blank">Care Oncology USA</a> website at <a href="https://careoncology.com/" rel="nofollow" target="_blank">https://careoncology.com/</a>.

Disarming Cancer Cells with the Safest Drugs Possible—Robin Bannister, Ph.D.—Care Oncology Clinic

Robin Bannister, Ph.D. had spent his professional life trying to understand the true nature of thousands of pharmaceuticals, including old ones which might be repurposed for the treatment of a number of diseases. When his wife was diagnosed with breast cancer in 2005 and it became metastatic in 2010, he knew he had to do something. There was no time to waste in trying to locate a drug which might extend her life, and he knew he didn’t have time to develop a new one. This was when he founded Care Oncology Clinic. Using what he’d learned about the great potential of repurposed drugs, he dove further into his work, narrowing down the list of 5,000 or so drugs that currently exist to a short, manageable list of drugs that are well-tolerated and associated with few side effects. In doing so, he identified drugs that make it difficult for cancer cells to survive in hostile environments and limit their defensive powers by limiting their energy source. In today’s podcast, you will discover:  What an efflux pump is and how exactly it’s used by cancer cells How the Care Oncology protocol utilizes an understanding of the Warburg effect to its advantage in treating patients Why the standard of care is not perfect, but often has a part to play in the treatment of cancer  Learn more by visiting the Care Oncology USA website at https://careoncology.com/.

Robin Bannister, Ph.D. had spent his professional life trying to understand the true nature of thousands of pharmaceuticals, including old ones which might be repurposed for the treatment of a number of diseases. When his wife was diagnosed with breast cancer in 2005 and it became metastatic in 2010, he knew he had to do something. There was no time to waste in trying to locate a drug which might extend her life, and he knew he didn’t have time to develop a new one. This was when he founded Care Oncology Clinic. Using what he’d learned about the great potential of repurposed drugs, he dove further into his work, narrowing down the list of 5,000 or so drugs that currently exist to a short, manageable list of drugs that are well-tolerated and associated with few side effects. In doing so, he identified drugs that make it difficult for cancer cells to survive in hostile environments and limit their defensive powers by limiting their energy source. In today’s podcast, you will discover: <ul> <li>What an efflux pump is and how exactly it’s used by cancer cells</li> <li>How the Care Oncology protocol utilizes an understanding of the Warburg effect to its advantage in treating patients</li> <li>Why the standard of care is not perfect, but often has a part to play in the treatment of cancer</li> </ul> Learn more by visiting the <a href="https://www.futuretechhealth.com/podcasts/concentration-on-cancer-dr-charles-j-meakin-medical-director-care-oncology-clinic-rethinking-the-drugs-and-methods-used-to-combat-cancer/" rel="nofollow" target="_blank">Care Oncology USA</a> website at <a href="https://careoncology.com/" rel="nofollow" target="_blank">https://careoncology.com/</a>.

Safely Stripping Away a Cancer Cell’s Defenses—Robin Bannister, Ph.D.—Care Oncology Clinic